On June 18, the grand annual event—the 24th CPHI China (Worldwide Exhibition for Pharmaceutical Ingredients China) alongside the 19th PMEC China (Worldwide Exhibition for Pharmaceutical Machinery, Packaging Equipment & Materials China)—concluded successfully in Shanghai.

Over the three-day exhibition, numerous industry elites gathered for business negotiations, exchanges and idea-sharing. Bangkai Materials showcased its full range of microporous silica products. Backed by our comprehensive layout across the entire pharmaceutical industrial chain and customized products & services, we built an efficient collaborative platform for new and long-term partners.

As a new material manufacturer specializing in silica for nearly two decades, Bangkai centered its exhibition display on microporous silica at this show. The company fully demonstrated its scenario-driven innovation capability of "One Core Base, Hundreds of Diversified Products" and customized product solution system of "Exclusive Program for Each Client". The booth drew crowds of professional domestic and overseas customers for in-depth exchanges, winning wide industry recognition and numerous cooperation intentions, which further strengthened technological collaboration and strategic ties with global partners.

The booth was continuously visited by professionals covering pharmaceutical preparations, APIs, excipients and health consumer products. From a simple handshake to in-depth business talks, and then to the preliminary planning of future cooperation blueprints — every conversation marked the starting point of a brand-new partnership.

Break New Ground with Technology, Forge Ahead with Craftsmanship

Upholding perseverance and innovation, we fuel the rise of domestic high-end silicon-based materials. We never follow trends blindly, never compromise on quality, and never stop advancing. Drawing on solid technical expertise and market exploration, we deliver reliable material solutions to every partner.

The exhibition may conclude, yet our cooperation continues. Taking this expo as a fresh starting point, the Bangkai team will further deepen strategic partnerships with clients at home and abroad, and jointly drive high-quality development of the pharmaceutical materials industry.